|
Evaxion A/S
(NASDAQ: EVAX)
|
9:00 PM UTC, 12/12/25 | |||
|---|---|---|---|---|
| Last: $6.21 | Change: -0.24 | %Change: -3.72% | Volume: 70,895 | |
11:05 AM EDT, 03/26/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were modestly lower late Wednesday morning, declining 0.31% to 1,424.06 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by furniture manufacturer Natuzzi (NTZ) and biotech firm Evaxion Biotech (EVAX), which rose 6.1% and 4.5% respectively. They were followed by biopharmaceutical company Genfit (GNFT) and oil and gas company TotalEnergies (TTE), which were up 3.5% and 2.8% respectively.
The decliners from continental Europe were led by software firm SAP (SAP) and medical device maker EDAP TMS (EDAP), which fell 2.7% and 1.4% respectively. They were followed by biopharmaceutical company argenx (ARGX) and internet browser company Opera (OPRA), which lost 2.5% and 1% respectively.
From the UK and Ireland, the gainers were led by oil and gas company Shell (SHEL) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which increased 1.9% and 0.3% respectively. They were followed by oil and gas company BP (BP) and medical device maker Smith & Nephew (SNN), which rose 1% and 0.8% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Mereo BioPharma Group (MREO), which dropped 5.8% and 3.2% respectively. They were followed by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company NuCana (NCNA), which were down 2.7% and 1.9% respectively.
http://www.mtnewswires.com
Copyright © 2025 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.